| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.4 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.4 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.041 | 0.4 |